“…Finally, the potential for resistance of organisms to ciclopirox may be lower than for other antifungals 7 . Thus ciclopirox has been used in multiple clinical trials for a wide variety of indications, and years of clinical usage have demonstrated the safety and efficacy of ciclopirox in the treatment of superficial mycoses 1,2,6,11,17,20,22–24 …”